Regulations.gov document
CDER Proposed Order_ Docket No. FDA-2022-N-2390 (Vanda Pharmaceuticals Inc. Hearing…
Other · FDA-2022-N-2390 · posted Jan 29, 2025
Key facts
| Document ID | FDA-2022-N-2390-0130 |
|---|---|
| Title | CDER Proposed Order_ Docket No. FDA-2022-N-2390 (Vanda Pharmaceuticals Inc. Hearing Request for sNDA 205677-012) |
| Document type | Other |
| Subtype | Electronic Letter |
| Agency | FDA |
| Docket | FDA-2022-N-2390 |
| Posted | Jan 29, 2025 |
| Comment period opens | Jan 29, 2025 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: